TSE •
Healthcare •
Biotechnology •
Quote as of 06/08/2026 15:30
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTSE
Market Capitalization8,056.52 mln
Float351 mln
Earnings Date08/07/2025
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-3.41
Reliable
Relative Strength
3
/ 100
Severely lagging
Debt / Equity
0.00
Debt-free
ROE
-60.48
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
OncoTherapy Science Inc. is a Japanese biotechnology company focused on developing new treatments for cancer and other serious diseases, including drugs derived from antibodies, cancer vaccines, and small molecule compounds. Founded in 2001 and based in Kawasaki, Japan, the company also conducts genomic research and liquid biopsy analysis to advance cancer detection and immunotherapy. Several of its treatments are currently progressing through clinical trials, targeting conditions such as leukemia, breast cancer, and gastric cancer, among others.
